Unidade de Radiobiologia, Centro de Desenvolvimento da Tecnologia Nuclear, Av. Presidente Antônio Carlos, 6627, Belo Horizonte, 31270-901, Brazil.
Serviço de Nanotecnologia, Centro de Desenvolvimento da Tecnologia Nuclear, Belo Horizonte, 31270-901, Brazil.
Nanomedicine (Lond). 2020 Dec;15(29):2823-2836. doi: 10.2217/nnm-2020-0313. Epub 2020 Nov 26.
Evaluation of the biocompatibility and radiosensitizer potential of citrate-coated cobalt (cit-CF) and nickel (cit-NF) ferrite nanoparticles (NPs). Normal fibroblast and breast cancer cells were treated with different concentrations of citrate-coated ferrite NPs (cit-NPs) and irradiated with a cobalt-60 source at doses of 1 and 3 Gy. After 24 h, cell metabolism, morphology alterations and nanoparticle uptake were evaluated. Cit-CF and cit-NF NPs showed no toxicity to normal cells up to 250 and 100 μg.ml, respectively. Combination of cit-NP and ionizing radiation resulted in up to fivefold increase in the radiation therapeutic efficacy against breast cancer cells. Cit-CF and cit-NF NPs are suitable candidates for application as breast cancer cell radiosensitizers.
评价柠檬酸涂层钴(cit-CF)和镍(cit-NF)铁氧体纳米粒子(NPs)的生物相容性和放射增敏剂潜力。用不同浓度的柠檬酸涂层铁氧体纳米粒子(cit-NPs)处理正常成纤维细胞和乳腺癌细胞,并在钴-60 源下以 1 和 3 Gy 的剂量照射。24 h 后,评估细胞代谢、形态改变和纳米颗粒摄取。柠檬酸涂层钴和柠檬酸涂层镍纳米粒子的浓度分别高达 250 和 100 μg/ml 时,对正常细胞没有毒性。柠檬酸镍纳米粒子与电离辐射的联合作用使乳腺癌细胞的放射治疗效果提高了五倍。柠檬酸涂层钴和柠檬酸涂层镍纳米粒子适合作为乳腺癌细胞放射增敏剂的应用。